Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 69.01 +1.45 (2.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $67.56 | 52 Week High | $13.18 | |||
| Open | $68.07 | 52 Week Low | $6.00 | |||
| Day High | $69.56 | P/E | N/A | |||
| Day Low | $67.87 | EPS | $-1.24 | |||
| Volume | 240,235 | |||||

